Literature DB >> 25983824

Intradural extramedullary ependymoma with spinal root attachment: a case report.

Seung Man Ha1, Dong Ah Shin2.   

Abstract

A 36-year-old female patient presented with shoulder pain experienced over a period of one year and progressive weakness in both legs for one month. A magnetic resonance imaging scan revealed an intradural extramedullary (IDEM) fusiform mass about 9.8 cm in length, heterogeneously enhanced at the level of C6-T4 with spinal cord compression. At the time of surgery, the surgeon found an encapsulated IDEM tumor with spinal root attachment. The tumor was completely resected and the histologic diagnosis revealed ependymoma. The patient showed a favorable outcome with no recurrence at the 6-month follow-up. This paper reports a rare case of intradural extramedullary ependymoma with spinal root attachment.

Entities:  

Keywords:  Ependymoma; Intradural extramedullary tumor; Spinal tumor; Surgery

Year:  2012        PMID: 25983824      PMCID: PMC4431011          DOI: 10.14245/kjs.2012.9.3.250

Source DB:  PubMed          Journal:  Korean J Spine        ISSN: 1738-2262


INTRODUCTION

Ependymoma is an uncommon group of glial tumors arising in the central nervous system. Spinal cord ependymoma comprises less than 2% of all central nervous system neoplasms, 15% of spinal cord tumors, and up to 60% of spinal cord gliomas20). It is an intramedullary lesion and there have been reports of only 17 cases of ependymomas arising in IDEM locations worldwide1,2,3,4,5,6,7,8,9,11,12,13,15,16,18,19). This is the fourth-reported case of primary IDEM ependymoma in South Korea10,14,17). However, it is the first cervico-thoracic-involved case of IDEM ependymoma with spinal root attachment.

CASE REPORT

A 36-year-old woman visited the hospital with complaints of progressive paraplegia, occurring for one month, and left shoulder pain of a year's duration. She had no past medical or surgical history. On the initial neurologic examination, the patient showed lower limb weakness (Grade III/III) in both limbs, hypoesthesia below T5, and bladder disturbance. Magnetic resonance imaging of the whole spine revealed an IDEM heterogeneously enhanced fusiform mass, about 9.8 cm in length, causing compression of the cord from the level of C6 upper body to T4 mid body (Fig. 1). Complete imaging of the rest of the neuroaxis revealed an arachnoid cyst in the right middle cranial fossa. The patient underwent surgical resection (Fig. 2). Surgeons performed a posterior C6 through T4 laminectomy, which allowed intradural exploration and removal of the IDEM mass, and a midline durotomy. The tumor was grossly yellowish in color and markedly distorted the spinal cord to the right. A stalk attached the tumor to the C7 spinal nerve root. The tumor was removed in a gross total fashion using standard microsurgical techniques. The patient tolerated the procedure well. Histological examination revealed a WHO Grade II ependymoma with a proliferation index of <1% measured by Ki-67 (Fig. 3). The patient's neurological status significantly improved after the surgery. Postoperative magnetic resonance imaging showed no definite residual enhancing mass. No adjuvant radiotherapy was offered to the patient. There was no recurrence on MRI at the 6-month follow up(Fig. 4).
Fig. 1

Pre-operative T1-weighted, post contrast sagittal (A) and axial (B) magnetic resonance images demonstrating an enhanced mass from the level of C6 upper body to T4 mid body.

Fig. 2

Intra-operative photograph shows a reddish, extramedullary encapsulated tumor after opening of the dura mater.

Fig. 3

Histologic examination reveals an ependymoma grade II. Tumor cells had round-to-oval nuclei. Eosinophilic cytoplasm and perivascular pseudorosette were evident.

Fig. 4

Six months later, a postoperative T1-weighted sagittal magnetic resonance image with gadolinium enhancement shows no recurrence of the gross total-resected tumor.

DISCUSSION

Spinal cord ependymoma is an intradural intramedullary lesion most frequently located at the conus medullaris or filum terminale. Only rare reports exist of spinal cord ependymomas in IDEM locations; only 17 cases of spinal cord ependymomas in IDEM locations exist in the relevant literature1,2,3,4,5,6,7,8,9,11,12,13,15,16,18,19). The overall prevalence of the majority of spinal ependymomas among males and females is equal but this neoplasm is more common in women; there were only 4 reported cases of male patients1,3,8,11). Although Duffau et al.5) has postulated the insufficiency of hormonal theory, there are no reports of hormonal assessment. There is no predominant age group for patients with this lesion. Typical clinical features include a slowly progressive myelopathy with weakness and pain according to tumor location. A thoracic location is a common presentation. Compared with almost all other IDEM ependymoma patients in the literature who presented with myelopathy and axial pain, the patient in the current case showed a unilateral, radicular symptom(shoulder pain) in addition to myelopathy, probably caused by root compression from the root attachment. In most previous reports, MRI showed typically well delineated IDEM tumors that were homogeneously enhanced after gadolinium administration. Doctors often diagnosed as schwannomas or meningiomas due to similarities in MRI findings and in clinical courses. Distinct from the other cases, the current case showed heterogenous enhancement, but intraoperative findings and pathologic findings were undistinguished16). More case reports are needed to clarify the pathogenesis and clinical manifestations of this type of tumor. In most previous reports, the lesions were encapsulated with only microvascular attachments to the central nervous system. This feature enabled complete resection. In two cases, there were thin stalks that connected the tumor to the spinal cord. In the case presented here, and in one reported by Bonfield et al.2) there were spinal nerve root attachments in the intraoperative findings. In the current case, the tumor was removed safely during surgery with an ultrasonic aspirator because of the loose attachment. It appears that this case is the second reported IDEM ependymoma involving a spinal nerve root2). Distinct from the current case, Bonfield et al.2) decided on the resection of nerve root because of the dense attachment. It is probable that the separated ectopic ependymal tissue during neural tube closure was the origin of the tumor on the nerve root11). Since prognosis is directly related to the extent of surgical resection, complete resection of the tumor is the optimal therapy for IDEM ependymoma. In this case, despite the nerve attachment, no residual tumor appeared in surgical findings or on postoperative magnetic resonance imaging; therefore, no adjuvant radiotherapy was warranted. If there are tumor remnants or malignant cases, adjuvant radiotherapy should be considered. There were no signs of local recurrence or distant dissemination on MRI at the 6-month follow-up and the patient had no neurologic deficits. However, since anaplastic transformation15) and recurrence1) have been reported in previous cases, regular follow-up evaluations are required.

CONCLUSION

This paper reports a rare case of intradural extramedullary ependymoma with spinal root attachment, which was successfully treated with gross total resection. Ependymoma should be included in the differential diagnosis of intradural extramedullary spinal cord tumors.
  17 in total

Review 1.  Cystic extramedullary ependymoma.

Authors:  J Graça; N Gültasli; N D'Haene; J Brotchi; I Salmon; D Balériaux
Journal:  AJNR Am J Neuroradiol       Date:  2006-04       Impact factor: 3.825

2.  Intradural extramedullary spinal anaplastic ependymoma. Case illustration.

Authors:  Alfonso Cerase; Carlo Venturi; Giuseppe Oliveri; Danilo De Falco; Clelia Miracco
Journal:  J Neurosurg Spine       Date:  2006-11

3.  Extramedullary thoracic myxopapillary ependymoma--a case report of a rare tumour.

Authors:  C H Cheng; T C Lee; H Y Huang; C C Lui
Journal:  Ann Acad Med Singapore       Date:  1996-11       Impact factor: 2.473

4.  [Giant dorsal extramedullary ependymoma].

Authors:  L González Feria; F Fernández Martín; M Ginovés Sierra; H Galera Davidson
Journal:  Arch Neurobiol (Madr)       Date:  1971 Jul-Aug

5.  [Dorsal extramedullary ependymoma (author's transl)].

Authors:  B Oliver; A de Castro; M A Sarmiento; C Argüello; M G Blaźquez
Journal:  Arch Neurobiol (Madr)       Date:  1981 Jul-Aug

6.  Intradural extramedullary spinal ependymoma: a benign pathology?

Authors:  Santiago Gil Robles; Cristobal Saldaña; Gregorio R Boto; Armando Martinez; Alvaro Perez Zamarron; Manuela Jorquera; Pedro Mata
Journal:  Spine (Phila Pa 1976)       Date:  2005-05-01       Impact factor: 3.468

7.  Extramedullary spinal ependymoma: a diagnostic challenge and review of the literature.

Authors:  Michael J Kinsman; James D Callahan; Eyas M Hattab; Aaron A Cohen-Gadol
Journal:  Clin Neurol Neurosurg       Date:  2011-03-24       Impact factor: 1.876

8.  Primary extramedullary ependymoma of the cervical spine : case report and review of the literature.

Authors:  Dong Wuk Son; Geun Sung Song; In Ho Han; Byung Kwan Choi
Journal:  J Korean Neurosurg Soc       Date:  2011-07-31

9.  Spinal extramedullary anaplastic ependymoma with spinal and intracranial metastases.

Authors:  Mascha Schuurmans; Jan A L Vanneste; Marco J T Verstegen; Wouter R van Furth
Journal:  J Neurooncol       Date:  2006-04-14       Impact factor: 4.130

10.  Intradural extramedullary ependymoma. A case report.

Authors:  S Katoh; T Ikata; A Inoue; M Takahashi
Journal:  Spine (Phila Pa 1976)       Date:  1995-09-15       Impact factor: 3.468

View more
  2 in total

1.  Multisegment Intradural Extramedullary Ependymoma.

Authors:  Rishika Trivedi; Pankaj Trivedi
Journal:  Cureus       Date:  2021-12-10

2.  A Case of Spinal Ependymoma Developed in the Extramedullary Location: A Case Report and Literature Review.

Authors:  Yasuhide Makino; Yoshifumi Kawanabe; Motoaki Fujimoto; Tsukasa Sato; Minoru Hoshimaru
Journal:  NMC Case Rep J       Date:  2021-09-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.